Terry Elton

Last updated

Terry S. Elton is an American professor of pharmacology at the Ohio State University.

Contents

Education and academic history

Terry Elton is a biochemist who received his B.S. from Weber State University in Chemistry, his Ph.D. in Biochemistry from Washington State University, and performed postdoctoral work at Washington State University and the University of Alabama. [1] As of 2019 Elton is a pharmacy professor and researcher at the Dorothy M. Davis Heart and Lung Research Institute at Ohio State. [2]

Scientific misconduct

Elton was first accused of scientific misconduct in 2010 after certain images in his published works seemed to be doctored, and was subjected to an internal investigation by an Ohio State pharmacy department committee. Elton was originally cleared of allegations of misconduct after the university's investigatory committee concluded that the “irregular” images were a result of disorganization, not “intentional malfeasance.” [3] However, in late December 2012, Elton was found guilty of scientific misconduct by both Ohio State University officials and the Office of Research Integrity. He was found to have falsified data in Western blots used to identify key proteins in his research into the brain chemistry of patients with Down syndrome. He also falsified Western blot data in a grant application to the National Institutes of Health. [4] [5] According to John Dahlberg, leader of the federal investigation into Elton's data, "It is clear from the PowerPoint that Dr. Elton has a long-standing convention of reusing figures to represent both control and experimental conditions. It would also appear that he has copied, resized/stretched/shrunk, darkened and flipped images (horizontally and vertically) ... to conceal similarities." [6]

In 2012 the Office of Research Integrity recommended that six of Elton's published papers be retracted, and he voluntarily entered a three-year exclusion agreement in which he excluded himself from any contracts or subcontracts with any U.S. government agency and serving as an adviser in any form to the Public Health Services. [7] Ohio State University also imposed its own penalties for Elton, including a prohibition from supervising any undergraduate or graduate students for three years, submitting all papers and grant applications to the university for review before proceeding with them for five years, and completing counseling on research misconduct and training on research ethics. [8]

As of 2020, seven of Elton's research papers have been retracted. [9]

Retracted papers

Chromosome 21-derived MicroRNAs Provide an Etiological Basis for Aberrant Protein Expression in Human Down Syndrome Brains This article was published in the Journal of Biological Chemistry. In this paper, Elton and his lab were working with five microRNA genes. The ultimate results suggesting that the inactivation of the miRNA gene, Has-21, might provide a therapeutic tool in the treatment of down syndrome. The paper was first published on November 6, 2009. By the time the paper was retracted, it had already been cited 34 times. The paper was retracted due to falsified and/or fabricated “western blots” in figures 2C, 2D, 2F, 3C, 3E, 4G, 5C and 5F.

Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts This article was published in Elsevier. In this paper, the hypothesis was that the down syndrome gene dosage overexpression of Has-21 miRNA causes a decreased expression of specific target proteins which in turn causes the neuronal and cardiac symptoms that Down syndrome patients experience. The paper was first published on April 1, 2008. By the time the paper was retracted it had already been cited 74 times. The paper was retracted due to falsified and/or fabricated Western blots in figures 3B, 3C, 3F, 3H, 3I and 3J.

The Human Angiotensin II Type 1 Receptor 1166 A/C Polymorphism Attenuates MicroRNA-155 Binding This article was published in the Journal of Biological Chemistry. This study by Elton's lab provided the first feasible biochemical mechanism by which the +1166 A/C polymorphism can lead to increased AT1R densities and possibly cardiovascular disease. The paper was first published on June 21, 2007. By the time the paper was retracted it had already been cited 184 times. The paper was retracted due to falsified and/or fabricated Western blots in figure 6 of the publication.

Transcriptional regulation of the AT1 receptor gene in immortalized human trophoblast cells This article was published in the Biochimica et Biophysica Acta or BBA (Latin for Biochemical and Biophysical Journal). This article explains a discovery of an immortalized human trophoblast cell line responds to AngII a peptide that regulates contraction of smooth vascular muscle, fluid homeostasis, and sympathetic nervous activity. The research also suggests that it can be synthesized in the placenta (gives nutrients and water to the fetus) which increases a gene that allows for less trophoblast invasiveness which is the main cause for Preeclampsia. The paper was retracted due to the fabricated blots in Figure 6. It has been cited six times. [10]

TGF-β1 regulation of human AT1 receptor mRNA splice variants harboring exon 2 This article was published in Molecular and Cellular Endocrinology. This article discusses how the inclusion of exon 2 in hAT1R mRNA transcripts dramatically decreases hAT1R protein levels and the responsiveness of Ang II. AT1R activation is closely associated with cardiovascular disease, the inclusion of exon 2 by alternative splicing represents a novel mechanism to reduce the overall production of the hAT1R protein and possibly limit the potential pathological effects of AT1R activation. This paper was retracted due to fabricated blots in Figures 5, 6B,7B,9B. This paper was cited 11 times. [11]

See also

Related Research Articles

Scientific misconduct is the violation of the standard codes of scholarly conduct and ethical behavior in the publication of professional scientific research. It is violation of scientific integrity: violation of the scientific method and of research ethics in science, including in the design, conduct, and reporting of research.

<span class="mw-page-title-main">Alternative splicing</span> Process by which a gene can code for multiple proteins

Alternative splicing, or alternative RNA splicing, or differential splicing, is an alternative splicing process during gene expression that allows a single gene to produce different splice variants. For example, some exons of a gene may be included within or excluded from the final RNA product of the gene. This means the exons are joined in different combinations, leading to different splice variants. In the case of protein-coding genes, the proteins translated from these splice variants may contain differences in their amino acid sequence and in their biological functions.

Genetics, a discipline of biology, is the science of heredity and variation in living organisms.

<span class="mw-page-title-main">Outline of biochemistry</span> Overview of and topical guide to biochemistry

The following outline is provided as an overview of and topical guide to biochemistry:

<span class="mw-page-title-main">Nonsense-mediated decay</span> Elimination of mRNA with premature stop codons in eukaryotes

Nonsense-mediated mRNA decay (NMD) is a surveillance pathway that exists in all eukaryotes. Its main function is to reduce errors in gene expression by eliminating mRNA transcripts that contain premature stop codons. Translation of these aberrant mRNAs could, in some cases, lead to deleterious gain-of-function or dominant-negative activity of the resulting proteins.

<span class="mw-page-title-main">Chromosome 4</span> Human chromosome

Chromosome 4 is one of the 23 pairs of chromosomes in humans. People normally have two copies of this chromosome. Chromosome 4 spans more than 193 million base pairs and represents between 6 and 6.5 percent of the total DNA in cells.

<span class="mw-page-title-main">Chromosome 19</span> Human chromosome

Chromosome 19 is one of the 23 pairs of chromosomes in humans. People normally have two copies of this chromosome. Chromosome 19 spans more than 61.7 million base pairs, the building material of DNA. It is considered the most gene-rich chromosome containing roughly 1,500 genes, despite accounting for only 2 percent of the human genome.

<span class="mw-page-title-main">GNAS complex locus</span> Gene locus

GNAS complex locus is a gene locus in humans. Its main product is the heterotrimeric G-protein alpha subunit Gs, a key component of G protein-coupled receptor-regulated adenylyl cyclase signal transduction pathways. GNAS stands for Guanine Nucleotide binding protein, Alpha Stimulating activity polypeptide.

Growth hormone-binding protein (GHBP) is a soluble carrier protein for growth hormone (GH). The full range of functions of GHBP remains to be determined however, current research suggests that the protein is associated with regulation of the GH availability and half-life in the circulatory system, as well as modulating GH receptor function.

<span class="mw-page-title-main">Betacellulin</span> Protein-coding gene in humans

Betacellulin is a protein that in humans is encoded by the BTC gene located on chromosome 4 at locus 4q13-q21. Betacellulin was initially identified as a mitogen. Betacellulin, is a part of an Epidermal Growth Factor (EGF) family and functions as a ligand for the epidermal growth factor receptor (EGFR). The role of betacellulin as an EGF is manifested differently in various tissues, and it has a great effect on nitrogen signaling in retinal pigment epithelial cells and vascular smooth muscle cells. While many studies attest a role for betacellulin in the differentiation of pancreatic β-cells, the last decade witnessed the association of betacellulin with many additional biological processes, ranging from reproduction to the control of neural stem cells. Betacellulin is a member of the EGF family of growth factors. It is synthesized primarily as a transmembrane precursor, which is then processed to mature molecule by proteolytic events.

R. Michael Roberts is an American biologist who is the Chancellor's Professor Emeritus of Animal sciences and Biochemistry at the University of Missouri. He is a founding co-editor of the Annual Review of Animal Biosciences, first published in 2013.

<span class="mw-page-title-main">Angiotensin II receptor type 1</span> Protein-coding gene in the species Homo sapiens

Angiotensin II receptor type 1(AT1) is a Gq/11-coupled G protein-coupled receptor (GPCR) and the best characterized angiotensin receptor. It is encoded in humans by the AGTR1 gene. AT1 has vasopressor effects and regulates aldosterone secretion. It is an important effector controlling blood pressure and volume in the cardiovascular system. Angiotensin II receptor blockers are drugs indicated for hypertension, diabetic nephropathy and congestive heart failure.

<span class="mw-page-title-main">RBM8A</span> Protein-coding gene in the species Homo sapiens

RNA-binding protein 8A is a protein that in humans is encoded by the RBM8A gene.

<span class="mw-page-title-main">Angiotensin II receptor type 2</span> Protein-coding gene in humans

Angiotensin II receptor type 2, also known as the AT2 receptor is a protein that in humans is encoded by the AGTR2 gene.

<span class="mw-page-title-main">Placental growth factor</span> Protein-coding gene in the species Homo sapiens

Placental growth factor(PlGF) is a protein that in humans is encoded by the PGF gene.

<span class="mw-page-title-main">GABRA3</span> Protein-coding gene in humans

Gamma-aminobutyric acid receptor subunit alpha-3 is a protein that in humans is encoded by the GABRA3 gene.

<span class="mw-page-title-main">ABCC9</span> Protein-coding gene in humans

ATP-binding cassette, sub-family C member 9 (ABCC9) also known as sulfonylurea receptor 2 (SUR2) is an ATP-binding cassette transporter that in humans is encoded by the ABCC9 gene.

Carlo Maria Croce is an Italian-American professor of medicine at Ohio State University, specializing in oncology and the molecular mechanisms underlying cancer. Croce and his research have attracted public attention because of multiple allegations of scientific misconduct.

In molecular biology mir-802 microRNA is a short RNA molecule. MicroRNAs function to regulate the expression levels of other genes by several mechanisms.

References

  1. "Terry S. Elton". Ohio State University. Retrieved 14 January 2013.
  2. Al-Ruwaishan, Abdulrahman (7 January 2013). "Ohio State pharmacy professor tampered with research data, hit with 'severe' federal sanctions". The Lantern. Retrieved 15 January 2013.
  3. Sutherly, Ben (6 January 2013). "Probe by OSU missed fraud". The Columbus Dispatch. Retrieved 15 January 2013.
  4. Sutherly, Ben (21 December 2012). "OSU professor to retract research over data-falsification finding". The Columbus Dispatch. Retrieved 15 January 2013.
  5. "Notices" (PDF). Federal Register. 77 (247): 76041–76042. 26 December 2012. PMC   5019595 . PMID   27737225 . Retrieved 15 January 2013.
  6. Sutherly, Ben (6 January 2013). "Probe by OSU missed fraud". The Columbus Dispatch. Retrieved 15 January 2013.
  7. Dahlberg, John. "Findings of Research Misconduct". Department of Health and Human Services. Retrieved 15 January 2013.
  8. Al-Ruwaishan, Abdulrahman (7 January 2013). "Ohio State pharmacy professor tampered with research data, hit with 'severe' federal sanctions". The Lantern. Retrieved 15 January 2013.
  9. "Retraction Watch Database - Terry Elton". Retraction Watch. The Center for Scientific Integrity. Retrieved 2020-05-06.
  10. Duffy, Aaron; Mickey Martin; Terry Elton (5 November 2004). "Transcriptional regulation of the AT1 receptor gene in immortalized human trophoblast cells". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1680 (3): 158–170. doi:10.1016/j.bbaexp.2004.09.008. PMID   15507319.
  11. Martin, Mickey; Jessica Buckenberger; Darren Knoell; Arthur Strauch; Terry Elton (25 April 2006). "TGF-β1 regulation of human AT1 receptor mRNA splice variants harboring exon 2". Molecular and Cellular Endocrinology. 249 (1–2): 21–31. doi:10.1016/j.mce.2006.01.009. PMID   16504375. S2CID   3838752. (Retracted, see doi:10.1016/j.mce.2016.08.003, PMID   27519873,  Retraction Watch . If this is an intentional citation to a retracted paper, please replace {{ retracted |...}} with {{ retracted |...|intentional=yes}}.)